IL‐2 is an important broad‐spectrum enhancer in the body that can enhance the activity of natural killer cells, and induce T lymphocytes to produce IFN, activating immune effector cells and producing synergistic effectors, that can effectively remove tumor and virus/bacteria‐infected cells (Gaffen & Liu, 2004). Here, IFNA1 is linked to neoplasm.